Brant Boren has a diverse work experience in the pharmaceutical industry. Brant worked at Kalyra Pharmaceuticals as a Senior Scientist, but further information about this role is not available. In 2020, they joined Zentalis Pharmaceuticals as a Principal Scientist. Prior to that, from 2010 to 2016, Brant worked at Senomyx as a Scientist. Brant started their career at Exelixis in 2007 as a Research Scientist I, where they contributed to various projects and co-authored patent applications. Before that, Brant was a Postdoc at The Scripps Research Institute from 2004 to 2007. Brant also served as a Graduate Student at Texas A&M University from 1998 to 2004.
Brant Boren's education history includes attending Ouachita Baptist University and Texas A&M University. It is not specified if Brant completed a degree or field of study at these institutions. Additionally, Brant was involved with the Sulikowski Lab, although no specific details about the role or duration are provided.
March, 2020 - present